Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
January 2022
in “
International Journal of Molecular Sciences
”
insulin resistance hyperandrogenism oral contraceptives antiandrogen agents insulin sensitizers ovulation inducers pioglitazone empagliflozin sitagliptin liraglutide simvastatin atorvastatin N-acetyl cysteine birth control pills antiandrogens ovulation stimulants Actos Jardiance Januvia Victoza Zocor Lipitor NAC
Studysummary This review summarizes factors involved in polycystic ovary syndrome pathogenesis and management, highlights commonly prescribed and repurposed medications, and calls for well-designed clinical trials to evaluate these treatments further.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on mdpi.com →